Lingfei Zhao

1.4k total citations
31 papers, 785 citations indexed

About

Lingfei Zhao is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Lingfei Zhao has authored 31 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Genetics, 15 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Lingfei Zhao's work include Mesenchymal stem cell research (16 papers), Tissue Engineering and Regenerative Medicine (8 papers) and Autophagy in Disease and Therapy (6 papers). Lingfei Zhao is often cited by papers focused on Mesenchymal stem cell research (16 papers), Tissue Engineering and Regenerative Medicine (8 papers) and Autophagy in Disease and Therapy (6 papers). Lingfei Zhao collaborates with scholars based in China and United States. Lingfei Zhao's co-authors include Chenxia Hu, Lanjuan Li, Jianghua Chen, Lanjuan Li, Hongbing Jiang, Lanjuan Li, Qiongling Bao, Lingjian Zhang, Zhongwen Wu and Jinfeng Duan and has published in prestigious journals such as Physical Review Letters, Scientific Reports and Advanced Science.

In The Last Decade

Lingfei Zhao

31 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingfei Zhao China 17 311 287 229 183 175 31 785
Lanjuan Li China 7 274 0.9× 301 1.0× 182 0.8× 88 0.5× 76 0.4× 12 672
Arash Sarveazad Iran 18 176 0.6× 130 0.5× 208 0.9× 80 0.4× 48 0.3× 70 906
Steven A. Bloomer United States 11 194 0.6× 81 0.3× 104 0.5× 154 0.8× 176 1.0× 22 631
Tiebing Zhu China 20 431 1.4× 104 0.4× 246 1.1× 87 0.5× 26 0.1× 47 1000
Helge Bruns Germany 19 259 0.8× 96 0.3× 565 2.5× 194 1.1× 474 2.7× 59 1.4k
Naoya Sawada Japan 14 273 0.9× 61 0.2× 98 0.4× 173 0.9× 59 0.3× 49 635
Wenzhi He China 13 364 1.2× 84 0.3× 88 0.4× 108 0.6× 31 0.2× 36 652
Jun–Kyu Suh South Korea 22 417 1.3× 51 0.2× 198 0.9× 94 0.5× 71 0.4× 65 1.3k
Sunad Rangarajan United States 15 351 1.1× 48 0.2× 144 0.6× 271 1.5× 28 0.2× 19 1.3k
Abhishek Aggarwal United States 21 430 1.4× 44 0.2× 132 0.6× 166 0.9× 77 0.4× 34 1.1k

Countries citing papers authored by Lingfei Zhao

Since Specialization
Citations

This map shows the geographic impact of Lingfei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfei Zhao more than expected).

Fields of papers citing papers by Lingfei Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingfei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfei Zhao. The network helps show where Lingfei Zhao may publish in the future.

Co-authorship network of co-authors of Lingfei Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Lingfei Zhao. A scholar is included among the top collaborators of Lingfei Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingfei Zhao. Lingfei Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Chun-Chia, Lingfei Zhao, Kenji Watanabe, et al.. (2025). Multiplet Supercurrents in a Josephson Circuit. Physical Review Letters. 134(6). 67001–67001. 1 indexed citations
2.
Liu, Zhixin, et al.. (2024). Knowledge, attitudes, and practices among patients with diabetes mellitus and hyperuricemia toward disease self-management. Frontiers in Public Health. 12. 1426259–1426259. 2 indexed citations
3.
Zhao, Lingfei, et al.. (2021). Combination of mesenchymal stromal cells and machine perfusion is a novel strategy for organ preservation in solid organ transplantation. Cell and Tissue Research. 384(1). 13–23. 2 indexed citations
4.
Hu, Chenxia, Lingfei Zhao, & Lanjuan Li. (2021). Genetic modification by overexpression of target gene in mesenchymal stromal cell for treating liver diseases. Journal of Molecular Medicine. 99(2). 179–192. 12 indexed citations
5.
Zhao, Lingfei, Chenxia Hu, Fei Han, et al.. (2021). Induction therapy with mesenchymal stromal cells in kidney transplantation: a meta-analysis. Stem Cell Research & Therapy. 12(1). 158–158. 5 indexed citations
6.
Duan, Jinfeng, et al.. (2021). Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment. Frontiers in Psychiatry. 11. 560138–560138. 10 indexed citations
7.
Zhao, Lingfei, et al.. (2020). Regenerative abilities of mesenchymal stem cells via acting as an ideal vehicle for subcellular component delivery in acute kidney injury. Journal of Cellular and Molecular Medicine. 24(9). 4882–4891. 9 indexed citations
8.
Hu, Chenxia, Lingfei Zhao, Miaoda Shen, Zhongwen Wu, & Lanjuan Li. (2020). Autophagy regulation is an effective strategy to improve the prognosis of chemically induced acute liver injury based on experimental studies. Journal of Cellular and Molecular Medicine. 24(15). 8315–8325. 16 indexed citations
9.
Hu, Chenxia, Lingfei Zhao, Zhongwen Wu, & Lanjuan Li. (2020). Transplantation of mesenchymal stem cells and their derivatives effectively promotes liver regeneration to attenuate acetaminophen-induced liver injury. Stem Cell Research & Therapy. 11(1). 88–88. 46 indexed citations
10.
Hu, Chenxia, et al.. (2020). Serum ammonia is a strong prognostic factor for patients with acute-on-chronic liver failure. Scientific Reports. 10(1). 16970–16970. 29 indexed citations
11.
Zhao, Lingfei, et al.. (2020). Preconditioning is an effective strategy for improving the efficiency of mesenchymal stem cells in kidney transplantation. Stem Cell Research & Therapy. 11(1). 197–197. 26 indexed citations
12.
Hu, Chenxia, Lingfei Zhao, Lingjian Zhang, Qiongling Bao, & Lanjuan Li. (2020). Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury. Stem Cell Research & Therapy. 11(1). 377–377. 107 indexed citations
13.
Chen, Yang, et al.. (2020). Can sacubitril/valsartan become the promising drug to delay the progression of chronic kidney disease?. Journal of Geriatric Cardiology. 17(12). 782–786. 2 indexed citations
14.
Zhao, Lingfei, et al.. (2019). Melatonin preconditioning is an effective strategy for mesenchymal stem cell‐based therapy for kidney disease. Journal of Cellular and Molecular Medicine. 24(1). 25–33. 37 indexed citations
15.
Hu, Chenxia, Lingfei Zhao, Jingjing Tao, & Lanjuan Li. (2019). Protective role of melatonin in early‐stage and end‐stage liver cirrhosis. Journal of Cellular and Molecular Medicine. 23(11). 7151–7162. 35 indexed citations
16.
Hu, Chenxia, Lingfei Zhao, Jinfeng Duan, & Lanjuan Li. (2019). Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis. Journal of Cellular and Molecular Medicine. 23(3). 1657–1670. 53 indexed citations
17.
Hu, Chenxia, Lingfei Zhao, & Lanjuan Li. (2019). Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases. Stem Cell Research & Therapy. 10(1). 199–199. 61 indexed citations
18.
Zhao, Lingfei, Fei Han, Junni Wang, & Jianghua Chen. (2019). Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models. Stem Cell Research & Therapy. 10(1). 385–385. 24 indexed citations
19.
Hu, Chenxia, Lingfei Zhao, Daxian Wu, & Lanjuan Li. (2019). Modulating autophagy in mesenchymal stem cells effectively protects against hypoxia- or ischemia-induced injury. Stem Cell Research & Therapy. 10(1). 120–120. 57 indexed citations
20.
Zhao, Lingfei, Chenxia Hu, Ping Zhang, Hongbing Jiang, & Jianghua Chen. (2018). Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury. Stem Cell Research & Therapy. 9(1). 225–225. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lanjuan Li Breakdown of academic impact, for papers by Arash Sarveazad Breakdown of academic impact, for papers by Steven A. Bloomer Breakdown of academic impact, for papers by Tiebing Zhu Breakdown of academic impact, for papers by Helge Bruns Breakdown of academic impact, for papers by Naoya Sawada Breakdown of academic impact, for papers by Wenzhi He Breakdown of academic impact, for papers by Jun–Kyu Suh Breakdown of academic impact, for papers by Sunad Rangarajan Breakdown of academic impact, for papers by Abhishek Aggarwal
Rankless by CCL
2026